Table of Contents
PPT Slide
PPT Slide
PPT Slide
PPT Slide
The Oral Drug Delivery Opportunity
Presentation Overview
eligen™ Oral Drug Delivery Technology
Provides Differentiated Solutions to the Traditional Challenges
Established Delivery Platform
PPT Slide
EMISPHERE® Delivery Agents
Patent Portfolio
Development Strategy
Product Candidates
PPT Slide
Osteoporosis: ($7 billion)Oral Salmon Calcitonin
Oral Salmon Calcitonin Status
Diabetes: ($13 Billion) Oral Insulin
PPT Slide
Oral Insulin:Benefits
PPT Slide
Oral Insulin: Potential First Line Therapy for Type 2 Diabetics
First Phase Insulin Release: Normal and Type 2 Diabetics
PPT Slide
Oral Insulin: Development Status
Oral Insulin: Next Steps
Anticoagulation: ($2.5 Billion) Oral Heparin
Oral Heparin: Status
PPT Slide
Risk Management
Financial Snapshot 6/30/03
Operating Efficiencies
Accomplishments 2003
Catalysts
Investment Thesis
PPT Slide
|